SEC Filings - Aerovate Therapeutics, Inc.

Filing date	Form	Description	View
January 8, 2020	D		0001798749-20-000001.pdf 0001798749-20-000001.rtf 0001798749-20-000001.xls View HTML
August 14, 2020	D		0001798749-20-000002.pdf 0001798749-20-000002.rtf 0001798749-20-000002.xls View HTML
July 12, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-21-091156.pdf 0001104659-21-091156.rtf 0001104659-21-091156.xls View HTML
July 12, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000929638-21-000897.pdf 0000929638-21-000897.rtf 0000929638-21-000897.xls View HTML
February 14, 2022	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-22-022817.pdf 0001104659-22-022817.rtf 0001104659-22-022817.xls View HTML
April 29, 2022	DEFA14A	Additional proxy soliciting materials - definitive	0001493152-22-011602.pdf 0001493152-22-011602.rtf 0001493152-22-011602.xls View HTML
April 19, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001798749-23-000030.pdf 0001798749-23-000030.rtf View HTML
June 17, 2021	S-1/A	Amended Registration statement for face-amount certificate companies	0001104659-21-082643.pdf 0001104659-21-082643.rtf 0001104659-21-082643.xls View HTML
June 24, 2021	S-1/A	Amended Registration statement for face-amount certificate companies	0001104659-21-084790.pdf 0001104659-21-084790.rtf 0001104659-21-084790.xls View HTML
June 25, 2021	S-1/A	Amended Registration statement for face-amount certificate companies	0001104659-21-085693.pdf 0001104659-21-085693.rtf 0001104659-21-085693.xls View HTML

Data provided by Kaleidoscope.